Hyperimmune immunoglobulin for hospitalised patients with COVID-19 (ITAC): a double-blind, placebo-controlled, phase 3, randomised trial

Author:

Polizzotto Mark N.,Nordwall Jacqueline,Babiker Abdel G.,Phillips Andrew,Vock David M.,Eriobu Nnakelu,Kwaghe Vivian,Paredes Roger,Mateu Lourdes,Ramachandruni Srikanth,Narang Rajeev,Jain Mamta K.,Lazarte Susana M.,Baker Jason V.,Frosch Anne E.P.,Poulakou Garyfallia,Syrigos Konstantinos N.,Arnoczy Gretchen S.,McBride Natalie A.,Robinson Philip A.,Sarafian Farjad,Bhagani Sanjay,Taha Hassan S.,Benfield Thomas,Liu Sean T.H.,Antoniadou Anastasia,Jensen Jens Ulrik Stæhr,Kalomenidis Ioannis,Susilo Adityo,Hariadi Prasetyo,Jensen MD Tomas O.,Morales-Rull Jose Luis,Helleberg Marie,Meegada Sreenath,Johansen Isik S.,Canario Daniel,Fernández-Cruz Eduardo,Metallidis Simeon,Shah Amish,Sakurai Aki,Koulouris Nikolaos G.,Trotman Robin,Weintrob Amy C.,Podlekareva Daria,Hadi Usman,Lloyd Kathryn M.,Røge Birgit Thorup,Saito Sho,Sweerus Kelly,Malin Jakob J.,Lübbert Christoph,Muñoz Jose,Cummings Matthew J.,Losso Marcelo H.,Turner Dan,Shaw-Saliba Kathryn,Dewar Robin,Highbarger Helene,Lallemand Perrine,Rehman Tauseef,Gerry Norman,Arlinda Dona,Chang Christina C.,Grund Birgit,Holbrook Michael R.,Holley Horace P.,Hudson Fleur,McNay Laura A.,Murray Daniel D.,Pett Sarah L.,Shaughnessy Megan,Smolskis Mary C.,Touloumi Giota,Wright Mary E.,Doyle Mittie K.,Popik Sharon,Hall Christine,Ramanathan Roshan,Cao Huyen,Mondou Elsa,Willis Todd,Thakuria Joseph V.,Yel Leman,Higgs Elizabeth,Kan Virginia L.,Lundgren Jens D.,Neaton James D.,Lane H. Clifford

Publisher

Elsevier BV

Subject

General Medicine

Reference36 articles.

1. Remdesivir for the treatment of COVID-19 - final report;Beigel;N Engl J Med,2020

2. Dexamethasone in hospitalized patients with COVID-19;Horby;N Engl J Med,2021

3. Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): preliminary results of a randomised, controlled, open-label, platform trial;Horby;Lancet,2021

4. Interleukin-6 receptor antagonists in critically ill patients with COVID-19;Gordon;N Engl J Med,2021

5. Antibody responses to SARS-CoV-2 in patients with COVID-19;Long;Nat Med,2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3